Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.91% Nasdaq Up0.87%

Chelsea Therapeutics International Ltd. (CHTP)

-NasdaqCM

2.45 Jun 18, 4:00PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 30, 2012Dec 30, 2011Dec 30, 2010
Total Revenue -   -   -  
Cost of Revenue -   -   -  
Gross Profit -   -   -  
Operating Expenses
Research Development16,744  37,270  30,871  
Selling General and Administrative12,901  13,344  6,631  
Non Recurring2,158   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (31,804) (50,614) (37,503)
Income from Continuing Operations
Total Other Income/Expenses Net68  162  243  
Earnings Before Interest And Taxes(31,736)(50,452)(37,260)
Interest Expense -   -  70  
Income Before Tax(31,736)(50,452)(37,330)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(31,736)(50,452)(37,330)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (31,736) (50,452) (37,330)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (31,736) (50,452) (37,330)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.